- Home
- EPOW vs CLSD Comparison
EPOW vs CLSD Comparison
Compare EPOW & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- CLSD
- Stock Information
- Founded
- EPOW 2014
- CLSD 2011
- Country
- EPOW China
- CLSD United States
- Employees
- EPOW N/A
- CLSD N/A
- Industry
- EPOW Business Services
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- CLSD Health Care
- Exchange
- EPOW Nasdaq
- CLSD Nasdaq
- Market Cap
- EPOW 24.1M
- CLSD 20.8M
- IPO Year
- EPOW 2021
- CLSD 2016
- Fundamental
- Price
- EPOW $1.33
- CLSD $3.94
- Analyst Decision
- EPOW
- CLSD Hold
- Analyst Count
- EPOW 0
- CLSD 4
- Target Price
- EPOW N/A
- CLSD $65.00
- AVG Volume (30 Days)
- EPOW 5.6M
- CLSD 61.8K
- Earning Date
- EPOW 05-15-2025
- CLSD 11-11-2025
- Dividend Yield
- EPOW N/A
- CLSD N/A
- EPS Growth
- EPOW N/A
- CLSD N/A
- EPS
- EPOW N/A
- CLSD N/A
- Revenue
- EPOW $64,997,741.00
- CLSD $4,166,000.00
- Revenue This Year
- EPOW N/A
- CLSD $98.20
- Revenue Next Year
- EPOW N/A
- CLSD $213.77
- P/E Ratio
- EPOW N/A
- CLSD N/A
- Revenue Growth
- EPOW 44.28
- CLSD N/A
- 52 Week Low
- EPOW $0.70
- CLSD $3.32
- 52 Week High
- EPOW $1.86
- CLSD $19.80
- Technical
- Relative Strength Index (RSI)
- EPOW 59.65
- CLSD 61.52
- Support Level
- EPOW $1.22
- CLSD $4.07
- Resistance Level
- EPOW $1.48
- CLSD $4.50
- Average True Range (ATR)
- EPOW 0.23
- CLSD 0.28
- MACD
- EPOW 0.01
- CLSD -0.13
- Stochastic Oscillator
- EPOW 49.53
- CLSD 26.49
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.